Tech Company Financing Transactions
SaNOtize Funding Round
Horizons Ventures, OurCrowd and Agricultural Bank of China participated in a $24 million venture round for SaNOtize. The round was recorded on 8/24/2022.
Transaction Overview
Company Name
Announced On
8/24/2022
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance its nitric oxide-based therapeutics pipeline, including its ongoing global Phase 3 nitric oxide nasal spray (NONS�) prevention clinical study with plans to recruit up to 3,000 participants in Canada and Sri Lanka.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8755 Ash St
Vancouver, British Columbia, V6P 6T3
CA
Vancouver, British Columbia, V6P 6T3
CA
Phone
Undisclosed
Website
Email Address
Overview
SaNOtize Research and Development Corp., is a rapidly growing pharmaceutical company focused on developing and commercializing high quality, innovative products. We aim to improve the quality of life for people throughout the world by using our proprietary biotechnology platform to remedy topical infections that negatively impact quality of life. Therapeutic targets include SARS-COV-2 (COVID-19), influenza, onychomycosis (nail fungus), chronic sinusitis, diabetic foot ulcers and others.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gilly Regev
Co-Founder
Chris Miller
Browse more venture capital transactions:
Prev: 8/24/2022: Distributed Finance venture capital transaction
Next: 8/24/2022: Pace by Object Software venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs